Posted On: 11/13/2015 4:00 PM
EMBARK – A study of enzalutamide + leuprolide for prostate cancer
1. Male age 18 or over
2. Prostate cancer initially treated by radical prostatectomy or radiotherapy
3. Meet PSA criteria
Sponsored by: Medivation
Length of Study: 5 years
Please contact one of our Clinical Research Coordinators today to find out more information if you are interested in this trial.
Research Department (315) 478-4185, option 7
Our Investigator for this study is Christopher Pieczonka, M.D.